Calcitonin receptor

Calcitonin Receptor (CALCR) is a G protein-coupled receptor that binds the hormone calcitonin. This receptor plays a crucial role in calcium homeostasis and the regulation of bone metabolism. The interaction between calcitonin and its receptor is vital for the maintenance of a healthy skeleton and for the prevention of osteoporosis. The calcitonin receptor is expressed in various tissues, including kidney, brain, and particularly in osteoclasts in the bone, where it inhibits bone resorption.

Structure

The calcitonin receptor is a member of the class B family of G protein-coupled receptors. It is composed of a large extracellular domain, seven transmembrane domains, and an intracellular C-terminal tail. The extracellular domain is responsible for binding calcitonin, while the transmembrane domains and the intracellular tail are involved in signal transduction upon hormone binding.

Function

Upon binding to calcitonin, the calcitonin receptor activates intracellular signaling pathways that lead to the inhibition of osteoclast activity. This results in a decrease in bone resorption, an increase in bone mass, and a reduction in blood calcium levels. The receptor is also involved in the regulation of kidney function and has been implicated in the control of food intake through its expression in the brain.

Clinical Significance

Mutations in the CALCR gene can lead to diseases affecting bone density and structure, such as familial isolated hyperparathyroidism and other forms of osteoporosis. The calcitonin receptor is also a target for the treatment of osteoporosis, with calcitonin being used therapeutically to inhibit bone resorption and to treat bone pain associated with the disease.

Pharmacology

Agonists of the calcitonin receptor, such as calcitonin itself, are used in the management of bone disorders. Antagonists and other modulators of the calcitonin receptor are under investigation for their potential therapeutic applications in diseases related to bone metabolism and calcium homeostasis.

Research Directions

Research on the calcitonin receptor includes studies on its structure-function relationships, the development of receptor agonists and antagonists, and the exploration of its role in diseases beyond bone metabolism. Understanding the mechanisms of receptor activation and signal transduction can lead to the development of new therapeutic strategies for osteoporosis and other metabolic bone diseases.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian